These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 14601763)

  • 1. Sequential conditional probability ratio tests for normalized test statistic on information time.
    Xiong X; Tan M; Boyett J
    Biometrics; 2003 Sep; 59(3):624-31. PubMed ID: 14601763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous and group sequential conditional probability ratio tests for phase II clinical trials.
    Tan M; Xiong X
    Stat Med; 1996 Oct; 15(19):2037-51. PubMed ID: 8896138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An additive boundary for group sequential designs with connection to conditional error.
    Xi D; Gallo P
    Stat Med; 2019 Oct; 38(23):4656-4669. PubMed ID: 31338847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A general formulation for a one-sided group sequential design.
    Moser BK; George SL
    Clin Trials; 2005; 2(6):519-28. PubMed ID: 16422312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A sequential procedure for monitoring clinical trials against historical controls.
    Xiong X; Tan M; Boyett J
    Stat Med; 2007 Mar; 26(7):1497-511. PubMed ID: 16900551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of methods for futility stopping based on conditional power.
    Lachin JM
    Stat Med; 2005 Sep; 24(18):2747-64. PubMed ID: 16134130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical trial designs based on sequential conditional probability ratio tests and reverse stochastic curtailing.
    Tan M; Xiong X; Kutner MH
    Biometrics; 1998 Jun; 54(2):682-95. PubMed ID: 9629648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An adaptive approach to implementing bivariate group sequential clinical trial designs.
    Todd S
    J Biopharm Stat; 2003 Nov; 13(4):605-19. PubMed ID: 14584711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple imputation for early stopping of a complex clinical trial.
    Betensky RA
    Biometrics; 1998 Mar; 54(1):229-42. PubMed ID: 9544518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Futility interim monitoring with control of type I and II error probabilities using the interim Z-value or confidence limit.
    Lachin JM
    Clin Trials; 2009 Dec; 6(6):565-73. PubMed ID: 19933716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal conditional error functions for the control of conditional power.
    Brannath W; Bauer P
    Biometrics; 2004 Sep; 60(3):715-23. PubMed ID: 15339294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimation of a parameter and its exact confidence interval following sequential sample size reestimation trials.
    Cheng Y; Shen Y
    Biometrics; 2004 Dec; 60(4):910-8. PubMed ID: 15606411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Group sequential tests for bivariate response: interim analyses of clinical trials with both efficacy and safety endpoints.
    Jennison C; Turnbull BW
    Biometrics; 1993 Sep; 49(3):741-52. PubMed ID: 8241370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adaptive sample size calculations in group sequential trials.
    Lehmacher W; Wassmer G
    Biometrics; 1999 Dec; 55(4):1286-90. PubMed ID: 11315085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Closed testing procedures for group sequential clinical trials with multiple endpoints.
    Tang DI; Geller NL
    Biometrics; 1999 Dec; 55(4):1188-92. PubMed ID: 11315066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adaptive group sequential designs for clinical trials: combining the advantages of adaptive and of classical group sequential approaches.
    Müller HH; Schäfer H
    Biometrics; 2001 Sep; 57(3):886-91. PubMed ID: 11550941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changing frequency of interim analysis in sequential monitoring.
    Lan KK; DeMets DL
    Biometrics; 1989 Sep; 45(3):1017-20. PubMed ID: 2790114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-Arm Phase II Group Sequential Trial Design with Survival Endpoint at a Fixed Time Point.
    Wu J; Xiong X
    Stat Biopharm Res; 2014; 6(4):289-301. PubMed ID: 28890756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Group sequential designs for monitoring survival probabilities.
    Lin DY; Shen L; Ying Z; Breslow NE
    Biometrics; 1996 Sep; 52(3):1033-41. PubMed ID: 8805766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A sequential conditional probability ratio test procedure for comparing diagnostic tests.
    Tang L; Tan M; Zhou XH
    J Appl Stat; 2011 Aug; 38(8):1623-1632. PubMed ID: 22523441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.